Mekky MA. To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy. World J Hepatol 2014; 6(4): 226-229 [PMID: 24799991 DOI: 10.4254/wjh.v6.i4.226]
Corresponding Author of This Article
Mohamed A Mekky, MD, PhD, Department of Tropical Medicine and Gastroenterology, Assiut University Hospital, Assiut 71111, Egypt. doc_mekky0000@yahoo.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/